SAB Biotherapeutics to List on Nasdaq through merger with Big Cypress Acquisition

SAB Biotherapeutics a clinical-stage biopharmaceutical announces definitive merger agreement with Big Cypress Acquisition Corp. (BCYP); the combined company will be listed on NASDAQ.
Read More